Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
about
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulActivity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibioticsEfficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model.Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.Enterococcal endocarditis: can we win the war?Mechanisms of antibiotic resistance in enterococci.The rise of the Enterococcus: beyond vancomycin resistance.Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin.Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci.Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies
P2860
Q33695596-FC38076F-844D-4CBA-8500-04B9E4417BB8Q33700022-884E35DF-A3B8-454C-9509-2732FD95C0C5Q33975885-7D2FC0F6-3B11-4658-9213-27F608A7190AQ33978060-57D8750A-D94A-480B-BC89-372893B6AEDFQ33979939-120062FF-EEB1-45DB-93F4-14E58920B47AQ33981033-21DB9FDA-F040-47DD-9665-EA6DFF212D7DQ35139489-0FCA29C8-6ED5-4A53-9D92-A58FF6CCB64CQ35610638-6F55EC6E-3874-4D27-B017-539473981A82Q35610646-1ED82C7B-1C9F-4104-A787-CAEF5E8E181CQ36752156-8A36FDC0-A7FB-48EC-A01F-EE2FC380CDF2Q36880156-41A3FC6A-6965-4CA6-A966-ED169BFC2A02Q39557698-5FF4527B-2AB1-4482-AF9E-3EED184D3607Q39558239-43E201EE-00CD-4188-938C-E118847A029CQ39651592-56DFFCF2-FA1D-4E3D-B19F-7BD80B660235Q42728978-DF61626D-8F67-4463-9EAB-95158946469E
P2860
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Influence of inducible cross-r ...... ith experimental endocarditis.
@ast
Influence of inducible cross-r ...... ith experimental endocarditis.
@en
type
label
Influence of inducible cross-r ...... ith experimental endocarditis.
@ast
Influence of inducible cross-r ...... ith experimental endocarditis.
@en
prefLabel
Influence of inducible cross-r ...... ith experimental endocarditis.
@ast
Influence of inducible cross-r ...... ith experimental endocarditis.
@en
P2093
P2860
P1476
Influence of inducible cross-r ...... ith experimental endocarditis.
@en
P2093
P2860
P304
P407
P577
1997-05-01T00:00:00Z